Pharmafile Logo

Portfolio analysis: Making Go/No-Go decisions to optimise the portfolio

Tuesday 20th March 2018 11:00 EST / 16:00 GMT / 17:00 CEST

Register now: http://bit.ly/2FnXsFx

When a pharma company is either considering acquiring a new agent, or developing one in-house, marketers need to understand the impact on the overall portfolio and decide whether to make a go or no-go decision on that asset.Join US Directors Tom Nolte and Melinda Shorr for this webinar which shows you how market research insights allow you to make confident go/no-go decisions in portfolio planning.

They will address:

Why portfolios need to adapt and change
Success today is not necessarily success tomorrow. Depth and diversification are essential to a strong portfolio – we explore the reasons why you need to actively plan for the future.

Considerations for Go/No-go research design for portfolio planning
We show you how to create an effective market research programme – what stakeholders needs to be involved in the planning process, what questions need to be asked and what methods can be used.

Determining value and magnitude metrics
We discuss the criteria by which additions to a pipeline fit into the key metrics – what value they bring to the portfolio and the size of that opportunity (magnitude). Conversely we will look at what the removal of an asset has on the overall portfolio.

Speed of decision-making
If agents are being developed in-house, evaluations can be made slowly and rigorously. When agents are being acquired, the decision to go or no-go often needs to be made quickly. We discuss the impact on market research design. 
Our presenters will also use a case study to demonstrate how market research insights support better decision-making on new agents in a portfolio.

Question and answer session
Following the presentation there will be a live Q&A where they will address any specific challenges you have encountered or concerns you may have about conducting portfolio analysis studies. We welcome you to submit your questions in advance when you register.

Register now: http://bit.ly/2FnXsFx

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Webcast: Virtual Q&A session – The future of digital health

In this webcast, Senior Director, Richard Head and Director of The Medical Futurist, Dr. Bertalan Mesko host a live virtual Q&A discussion about the future of digital health.

Research Partnership is on the rise

Research Partnership ranks 12th in fastest growing UK market research agency league  tables

What does the future hold for Light-chain Amyloidosis?

Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...

Webcast: Securing a future for telehealth with immersive market research insights

Research Partnership investigate the current landscape, the challenges to adoption and the future for telehealth.

Breaking the silence: It’s time to talk about the menopause

Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change.

News:

Senior Analytics Specialist joins Research Partnership

Article:

All change – how untangling human behaviour can encourage better health

Webcast:

Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy

News:

Therapy Watch COVID-19 tracker

Events:

Patient Centricity and Engagement Conference 2021